91´«Ã½

was selected as a member of WHO technical advisory committee on Covid-19. WHO(World Health Organization) has established a Technical Advisory Group (TAG) to advise on scientific, technical and strategic matters related to the COVID-19 Technology Access Pool (C-TAP). The group is composed of 10 renowned experts with a diverse range of knowledge and expertise as clinicians and researchers working on COVID-19 health products; experts in access to medicines, diagnostics, vaccines and other health products; specialists of public health-oriented intellectual property; technology transfer experts; business development experts; experts in pricing, procurement, needs estimation and/or regulation of medicines.

USJ Congratulates Prof. Neelika Malavige on the well deserved position as a member of WHO technical advisory committee, recognizing the tireless efforts in fighting Covid-19 pandemic. The 91´«Ã½ wishes her all the best for all her future endeavors.

News source : 

 

 

Read research articles of :

90 percent of the new cases in Colombo belonged to the Delta variant says Dr. Jeewandara

Over 95% individuals developed antibodies against the Sinopharm vaccine – USJ Researchers

Research on Immunological response to COVID-19 vaccines by the Department of Immunology and Molecular Medicine, USJ

Single dose of Sputnik V is highly effective but second dose is beneficial says USJ researchers

USJ researchers found Four mutant Covid Delta variants with two new 91´«Ã½n mutations (A701S, R24C)

Delta variant was responsible for 95.8% of Covid-19 infections in 91´«Ã½ – Allergy, Immunology Cell Biology Unit, USJ

Whole genomic sequencing of the SARS-CoV-2 variants in 91´«Ã½ issued by Dept. of Immunology and Molecular Medicine USJ

The delta variant in 91´«Ã½ assigned a new sub-lineage (AY.28)

Antibody responses declined but T cell responses remained 12 weeks after Sinopharm second dose – USJ research